Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06417385 · ClinicalTrials.gov registry record · NA

taVNS-Paired Breastfeeding to Improve Breastfeeding at Discharge

A NA study of Premature Birth and Breastfeeding, Exclusive, sponsored by Medical University of South Carolina.

Recruiting
Registry status
NA
Development phase
10
Enrollment target
1
Study location

NCT06417385: Recruiting NA study of Premature Birth and Breastfeeding, Exclusive, sponsored by Medical University of South Carolina.

NCT06417385 is a NA study of Premature Birth and Breastfeeding, Exclusive that is actively recruiting participants, run by Medical University of South Carolina. The registered enrollment target is 10 participants, below the 394-participant average among 38 other Premature Birth trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06417385, a NA study of Premature Birth and Breastfeeding, Exclusive, is actively recruiting participants, sponsored by Medical University of South Carolina.

RECRUITING
Registry status
NA
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

Investigators aim to improve the skills of premature or sick term infants in breastfeeding by boosting motor learning with transcutaneous vagus nerve stimulation. Investigators will recruit 10 premature, ≥ 35 weeks gestational age, or convalescing sick term infants admitted to the NICU at MUSC to participate in this study. Infants will receive taVNS treatments once a day with breastfeeding's for up to 14 days. Before each treatment, the researcher will determine how much electrical stimulation is needed for the infant to feel a slight tingle without discomfort, and during daily treatment paired with breastfeeding the infant will continue to receive this level of electrical stimulation, coinciding with latching and sucking, repeated over the duration of the feed. Investigators will collect information about the pre- and post-feed weights, the length of time for each feed, and observations of latch, suck, and swallow techniques by the infant from parents and the lactation consultant. Investigators will also evaluate parental satisfaction associated with their infant's ability to breastfeed after taVNS by providing parental satisfaction surveys at the beginning, after 1 and 2 weeks, and at 3 months after the end of the study to assess infants' progress in and maintenance of breastfeeding abilities. If the pairing of breastfeeding with taVNS is able to result in improved outcomes of effective breastfeeding in infants in the neonatal intensive care units, this intervention could be further utilized by NICUs to increase the rate of premature and sick term infants who are successfully able to breastfeed at the time of discharge and maintain breast feeding longer after discharge. This would allow premature infants to acquire the many benefits of breastmilk as well as contribute towards the strengthening of the maternal-infant bond that breastfeeding has been shown to enhance.

Primary Outcome

Measured by pre- and post-feed weights (grams)

Interventions

  • DEVICE taVNS soterix device

Study Locations (1)

South Carolina

  • Medical University of South Carolina Shawn Jenkins Children's Hospital - Charleston

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2024-02-01
Est. Completion 2027-06-01
Phase NA

What NCT06417385 shows while recruiting

NCT06417385 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 394-participant average among 38 other Premature Birth trials with a reported enrollment target (97% lower).

The record links to 3 conditions, with Premature Birth appearing as the primary indexed condition, and to 1 intervention - of which taVNS soterix device is the first listed.

NCT06417385 reports a single indexed study location in South Carolina.

Frequently Asked Questions

What is clinical trial NCT06417385 about?

NCT06417385 is a clinical study titled "taVNS-Paired Breastfeeding to Improve Breastfeeding at Discharge". Investigators aim to improve the skills of premature or sick term infants in breastfeeding by boosting motor learning with transcutaneous vagus nerve stimulation. Investigators will recruit 10 premature, ≥ 35 weeks gestational age, or convalescing sick term infants admitted to the NICU at MUSC to pa...

What is the current status of trial NCT06417385?

This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2024-02-01. Estimated completion is 2027-06-01.

What conditions does trial NCT06417385 study?

This clinical trial studies the following conditions: Premature Birth, Breastfeeding, Exclusive, Feeding; Difficult, Newborn.

What interventions are being tested in trial NCT06417385?

The interventions under investigation include: taVNS soterix device (DEVICE).

Who is sponsoring clinical trial NCT06417385?

This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06417385 being conducted?

This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Premature Birth

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06417385's enrollment target sits among peer trials

10 39th of 38 the lowest of 38 other Premature Birth trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Premature Birth trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06417385, the US trial registry maintained by the National Library of Medicine. NCT06417385 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.